NO306511B1 - Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide - Google Patents

Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide

Info

Publication number
NO306511B1
NO306511B1 NO955101A NO955101A NO306511B1 NO 306511 B1 NO306511 B1 NO 306511B1 NO 955101 A NO955101 A NO 955101A NO 955101 A NO955101 A NO 955101A NO 306511 B1 NO306511 B1 NO 306511B1
Authority
NO
Norway
Prior art keywords
vector
hcv
hepatitis
genome
virus
Prior art date
Application number
NO955101A
Other languages
Norwegian (no)
Other versions
NO955101L (en
NO955101D0 (en
Inventor
Michael Houghton
Qui-Lin Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO892931A external-priority patent/NO304990B1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO955101L publication Critical patent/NO955101L/en
Publication of NO955101D0 publication Critical patent/NO955101D0/en
Publication of NO306511B1 publication Critical patent/NO306511B1/en

Links

NO955101A 1987-11-18 1995-12-15 Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide NO306511B1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12271487A 1987-11-18 1987-11-18
US13988687A 1987-12-30 1987-12-30
US16107288A 1988-02-26 1988-02-26
US19126388A 1988-05-06 1988-05-06
US26358488A 1988-10-26 1988-10-26
US27145088A 1988-11-14 1988-11-14
NO892931A NO304990B1 (en) 1987-11-18 1989-07-17 Polypeptide comprising HCV, NANBV, antigenic determinant, fusion protein, immunoassay, NANBV diagnostics, immunoassay kit and antibody composition

Publications (3)

Publication Number Publication Date
NO955101L NO955101L (en) 1995-12-15
NO955101D0 NO955101D0 (en) 1995-12-15
NO306511B1 true NO306511B1 (en) 1999-11-15

Family

ID=27567204

Family Applications (2)

Application Number Title Priority Date Filing Date
NO955102A NO303879B1 (en) 1987-11-18 1995-12-15 HCV polynucleotides and their use as primary in a polymerase chain reaction
NO955101A NO306511B1 (en) 1987-11-18 1995-12-15 Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO955102A NO303879B1 (en) 1987-11-18 1995-12-15 HCV polynucleotides and their use as primary in a polymerase chain reaction

Country Status (1)

Country Link
NO (2) NO303879B1 (en)

Also Published As

Publication number Publication date
NO955101L (en) 1995-12-15
NO955102L (en) 1995-12-15
NO955101D0 (en) 1995-12-15
NO955102D0 (en) 1995-12-15
NO303879B1 (en) 1998-09-14

Similar Documents

Publication Publication Date Title
FI107610B (en) HCV fusion protein
DK0624195T3 (en) New biologically active polypeptides, their preparation, and pharmaceutical compositions containing these polypeptides
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
NO934019L (en) Genomic HCV sequences for diagnostic and therapeutic purposes
ES2002490A6 (en) Vaccines and immunoassays for acquired immune deficiency syndrome
EP0992580A3 (en) Immunodominant human T-cell epitopes of Hepatitis C virus
IE800991L (en) HBs Ag GENE AND PRODUCT
YU48038B (en) PROCEDURE FOR DIAGNOSIS OF NO-A, NO-V HEPATITIS
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
DK314485D0 (en) DERIVATIVES OF HUMANT INTERFERON-GAMMA POLYPEPTIDE, RECOMBINANT PLASMIDE USED IN PREPARING THEREOF, PROCEDURES FOR PRODUCING THEREOF AND MICROORGANISM CONTAINING RECOMBINANT PLASMID
DK0632129T3 (en) Recombinant foamy virus vectors for medical and diagnostic use, and methods for preparing recombinant foamy virus vectors
EP0437610A4 (en) Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
EP0252588A3 (en) Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
NO922728L (en) Vaccine against COCCIDIOSIS
NO306511B1 (en) Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
IL88371A0 (en) Directed integration of genes into a plant genome and recombinant dna,expression vectors and host cells used therefor
EP0503950A3 (en) Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells
NO178931C (en) Process for Preparation of a Primarily Clean, Therapeutically Active Antigenic Protein, and Expression System of a Recombinant Virus
PT89041A (en) Purified hepatitis C virus - and associated nucleic acids and polypeptide(s)
HK70594A (en) A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein
Zaslavsky Molecular biology of RNA animal viruses of agricultural importance and applied aspects in veterinary medicine. Part I. Picornaviruses.
SU1380209A1 (en) RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE
GB9107472D0 (en) Method of producing recombinant viruses using linearised viral dna and vectors therefor
DK164283C (en) POLYPEPTIDE WITH CYSTATIN C ACTIVITY, DNA SEQUENCE FOR EXPRESSION OF 3-DES-OH CYSTATIN C OR A MODIFICATION THEREOF, PROCEDURES FOR THE PREPARATION OF 3-DES-HYDROXY-CYSTATINE MELDOMMANE MADRIDME OR MADIFICANE MADRIDME USE OF 3-DES-OH CYSTATIN C OR ITS MODIFICATION FOR THE PREPARATION OF A THERAPEUTIC PREPARATION